about
Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma[Vitamin B12 deficiency. New data on an old theme].Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resection.A pilot study of confocal laser endomicroscopy for diagnosing gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma.Anatomy of the GI tract in US: an historical perspective.A phase II study of bortezomib in patients with MALT lymphomaPhotodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications.Efficacy and safety of bovine activated factors IIa/VIIa/IXa/Xa in patients with active gastrointestinal bleeding: a proof of concept study.Endoscopic versus surgical management of biliary complications - Outcome analysis after 1188 orthotopic liver transplantations.A retrospective study on the safety, diagnostic yield, and therapeutic effects of endoscopic unroofing for small gastric subepithelial tumors.Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment.Second complete remission of Helicobacter pylori negative gastric MALT lymphoma following antibiotic treatment.Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongue.18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum.Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).Ingested matter affects intestinal lesions in Crohn's disease.Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology GrouComparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.A multicenter prospective study on the diagnostic performance of a new liquid rapid urease test for the diagnosis of Helicobacter pylori infection.The Human Gastric Microbiome Is Predicated upon Infection with Helicobacter pylori.Endoscopic ultrasound guided therapy of benign and malignant biliary obstruction: a case series.Successful management of benign biliary strictures with fully covered self-expanding metal stents.[Influence of technical advancements on the management of biliary tract diseases].Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications.Comparison of spiral-computed tomography with water-filling of the stomach and endosonography for gastric lymphoma of mucosa-associated lymphoid tissue-type.Heterogeneous penetration of cefpirome and moxifloxacin into abscesses after simultaneous administration in humans.Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 CasesBarrett-ÖsophagusSecond line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysisAbscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pusGood penetration of moxifloxacin into human abscesses[Austrian benchmarking project for ERCP: a 10-year report][Neuroendocrine tumors in daily gastroenterology and endoscopy - a practice manual]
P50
Q28263800-E3A54BA0-0D7A-436F-9A94-F2291F1B1D03Q31028698-897FE6EB-0791-4104-93D7-88C5C3C09B5CQ34544349-810584F3-307E-48F3-AAC4-AC0DDD1AE76BQ34574005-A15DD318-EC69-4F35-8749-6C58C05BAE63Q35579697-9AD2A7DA-E304-46DD-9388-CFA61FBD174EQ35815449-423246A0-0BC6-494F-B54D-4DFD794AA01BQ36044952-A1EA5332-ED84-4329-89CA-963A1CE6FFDAQ37175630-CBC326C2-487B-4EB6-BD82-99236CF4E1D7Q37741835-4E1810CB-6CF1-40B5-87ED-4F4FAF967D41Q38400291-3053DEE9-2112-45B3-9F0C-D0547FD3300EQ38867455-C051648A-F5E5-4F9A-8A07-680898DCC242Q39826524-14E3BE41-0706-4654-8AE2-8A5184B34847Q43635791-F38AEB2E-1E18-4694-A455-39A07F693365Q43877750-0B3083D9-EB6D-4AA4-8214-518D91C71CF6Q43978041-F59FF2B6-FC23-4322-BBFC-77910ED23152Q44480032-4128E834-5F6F-4276-A393-B57F48E73621Q44827505-EDFBCF50-ECC0-49D9-BA01-90491BCADA38Q45053433-1E737015-D245-4A3D-8762-34409CDCB689Q45394131-BC08E8D3-A5B2-40DF-94D8-D0CAB44649A7Q46121484-C0CC7448-0BCF-40BB-8F2D-0F55C8EA83B5Q46640459-4EA40EA3-8D85-40FD-BCAD-17DCE384AB82Q46882351-C922B681-8FA4-4412-A56B-2BB5636978B3Q47096756-AB2377B0-2E38-4233-8A64-B999F6D63AA4Q50130703-C77321BD-2AA1-40F2-8E1A-EB74310BBD13Q50166783-C14A5B75-7397-43DC-9161-51131E0F16F8Q50183426-35C695BE-54AB-4971-BB2F-0DD3F49A3803Q50194548-88F8AD24-49C1-4F37-8BDD-0C6C0849D4C7Q51187423-FD84F1EE-1DAF-40C5-A6BB-86D218D8044BQ53670677-CED99768-5184-4CBF-8368-FAB535FF5F4CQ55462444-8E09D5C4-F083-4FE1-B38F-E538EF1E91D2Q58956389-1A12816C-D3C9-45CF-8A95-0B1FF066BF1CQ59460735-F60334D9-3D33-4CAB-A5EE-C69E2A13CA1BQ64041589-7F01ADF1-87D3-4EA7-8288-87A3DB8C18A0Q83730933-3C79C018-BC95-408F-B2F3-8C4523904953Q84740652-1CDB1D9A-2F78-4172-B200-6B4B0990546FQ90944009-06452C84-8EDF-4F1B-AA18-31D7150E858DQ91883259-8A513061-B609-4F02-95A4-D98A5CCD74C4
P50
name
Andreas Püspök
@en
Andreas Püspök
@nl
type
label
Andreas Püspök
@en
Andreas Püspök
@nl
prefLabel
Andreas Püspök
@en
Andreas Püspök
@nl